We are live on ! Find out more
TCRR

TCR2 Therapeutics Inc. Common Stock
TCRR

Delisted

TCRR was delisted on the 31st of May, 2023.

Back to rankings

119 hedge funds and large institutions have $572M invested in TCR2 Therapeutics Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 49 increasing their positions, 34 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

44% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 34

8% less funds holding

Funds holding: 129 → 119 (-10)

31% less capital invested

Capital invested by funds: $834M → $572M (-$263M)

43% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 23

76% less call options, than puts

Call options by funds: $1.46M | Put options by funds: $6.06M

Holders
119
Holders Change
-10
Holders Change %
-7.75%
% of All Funds
2.07%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
13
Increased
49
Reduced
34
Closed
23
Calls
$1.46M
Puts
$6.06M
Net Calls
-$4.6M
Net Calls Change
-$3.85M

Top Buyers

Rank Fund Capital Flow
1
CS
Candriam SCA
Luxembourg
+$10.9M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$8.04M
3
Morgan Stanley
Morgan Stanley
New York
+$3.13M
4
RCAMU
Rothschild & Co Asset Management US
Connecticut
+$2.66M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$1.92M

Top Sellers

Rank Fund Capital Flow
1
Victory Capital Management
Victory Capital Management
Texas
-$22.1M
2
MWNA
Marshall Wace North America
New York
-$11.1M
3
CAM
Cormorant Asset Management
Massachusetts
-$8.49M
4
RG
Redmile Group
California
-$7.57M
5
PA
Perceptive Advisors
New York
-$5.71M
Name Holding Trade Value Shares
Change 		Change in
Stake
California State Teachers Retirement System (CalSTRS)
51
California State Teachers Retirement System (CalSTRS)
California
$690K -$32.3K -1,598 -4%
AA
52
AlphaCentric Advisors
Puerto Rico
$673K +$717K +35,500 +645%
RhumbLine Advisers
53
RhumbLine Advisers
Massachusetts
$611K +$7.58K +375 +1%
XSC
54
X-Square Capital
Puerto Rico
$587K – – –
Susquehanna International Group
55
Susquehanna International Group
Pennsylvania
$543K +$137K +6,787 +26%
GCP
56
GSA Capital Partners
United Kingdom
$524K +$443K +21,917 +219%
CSS
57
Cubist Systematic Strategies
Connecticut
$516K +$16.9K +835 +3%
PA
58
Perceptive Advisors
New York
$505K -$5.71M -282,547 -90%
CCM
59
Copernicus Capital Management
California
$492K +$606K +30,000 New
New York State Common Retirement Fund
60
New York State Common Retirement Fund
New York
$455K +$95.6K +4,734 +21%
AllianceBernstein
61
AllianceBernstein
Tennessee
$448K +$133K +6,600 +32%
GPCM
62
Granite Point Capital Management
Massachusetts
$394K – – –
US Bancorp
63
US Bancorp
Minnesota
$375K +$3.03K +150 +0.7%
Deutsche Bank
64
Deutsche Bank
Germany
$322K -$1.7M -84,394 -81%
AS
65
Altshuler Shaham
Israel
$305K – – –
State Board of Administration of Florida Retirement System
66
State Board of Administration of Florida Retirement System
Florida
$305K +$375K +18,566 New
Manulife (Manufacturers Life Insurance)
67
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$303K +$27.4K +1,356 +8%
IA
68
IndexIQ Advisors
New York
$301K -$18.2K -900 -5%
GT
69
Glenmede Trust
Pennsylvania
$264K -$14.4K -711 -4%
Millennium Management
70
Millennium Management
New York
$259K -$2.68M -132,536 -89%
DTL
71
Dynamic Technology Lab
Singapore
$257K +$83.4K +4,131 +36%
Mitsubishi UFJ Asset Management
72
Mitsubishi UFJ Asset Management
Japan
$255K +$57K +2,822 +22%
APP
73
Alpha Paradigm Partners
Illinois
$252K +$310K +15,341 New
UBS Group
74
UBS Group
Switzerland
$251K -$784K -38,808 -72%
ProShare Advisors
75
ProShare Advisors
Maryland
$242K +$35.9K +1,775 +14%
1 2
3
4 5

TCRR Hedge Fund Activity: Q2 2021 in Review

119 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in TCR2 Therapeutics Inc. Common Stock (TCRR) for Q2 2021, worth a combined $572M — down 31% from $834M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of TCRR and 13 opened new positions — a net loss of 10 holders — while 34 trimmed existing stakes and 49 added.

The largest buyer was Candriam SCA, adding an estimated $10.9M. The largest seller was Victory Capital Management, cutting an estimated $22.1M.

  • 119 institutional investors held TCR2 Therapeutics Inc. Common Stock (TCRR) as of Q2 2021, down from 129 in Q1 2021.
  • Funds reported $572M of TCR2 Therapeutics Inc. Common Stock stock for Q2 2021, down 31% quarter-over-quarter.
  • 13 funds opened new TCR2 Therapeutics Inc. Common Stock positions in Q2 2021 and 23 closed out, a net change of -10 holders.
  • The largest TCR2 Therapeutics Inc. Common Stock buyer in Q2 2021 was Candriam SCA, an estimated $10.9M added.
  • The largest TCR2 Therapeutics Inc. Common Stock seller in Q2 2021 was Victory Capital Management, an estimated $22.1M sold.

Based on aggregated 13F filings for Q2 2021.